Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin rectal tissue pharmacokinetics study
ACTRN12616001666415Phase 4Completed
- Sponsor
- University of Melbourne
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of azithromycin in Chlamydia trachomatis infection, sponsored by University of Melbourne. Primary endpoints: Anorectal tissue azithromycin concentration and Blood azithromycin concentration. Started Jan 2016; status: completed.
02
Drugs
azithromycin
03
Conditions
Chlamydia trachomatis infection
Beyond the preview
Go deeper on ACTRN12616001666415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001666415.